Erratum for

• Implementation and Evaluation of Primary Care Team Participation in Opioid Use Disorder Learning Sessions.

  Lutgen C, Callen E, Robertson E, Clay T, Filippi MK. Lutgen C, et al. Subst Abus. 2023 Jan-Apr;44(1):51-61. doi: 10.1177/08897077231174675. Epub 2023 May 11. Subst Abus. 2023. PMID: 37226899
• Perioperative Management of Extended-Release Buprenorphine: A Narrative Review and Case Series.

  Hickey TR, Meeks T, Oxentine H, Park DC, Abelleira A, Edens E, Gordon AJ, Acampora G. Hickey TR, et al. Subst Abus. 2023 Jan-Apr;44(1):96-103. doi: 10.1177/08897077231167043. Epub 2023 Apr 26. Subst Abus. 2023. PMID: 37226900 Review.
• Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals.

  Coyle DT, Stewart S, Bortz C, Manalo J, Ritvo A, Krsak M. Coyle DT, et al. Subst Abus. 2023 Jan-Apr;44(1):17-23. doi: 10.1177/08897077231165619. Epub 2023 Apr 26. Subst Abus. 2023. PMID: 37226901
• Sociodemographic Differences in Menthol Cigarette Use in the United States.

  Talluri R, Shete S. Talluri R, et al. Subst Abus. 2023 Jan-Apr;44(1):91-95. doi: 10.1177/08897077231174683. Epub 2023 May 13. Subst Abus. 2023. PMID: 37226902 Free PMC article.
• The Creation of an Addiction Nursing Fellowship Program for Registered Nurses: A Unique Approach to Enhancing the Addiction-Treatment Workforce.

  Fox JM, Wason K, Beers D, Faulds M, Lincoln N, Tomanovich M, Gaden NW, Komaromy Md M. Fox JM, et al. Subst Abus. 2023 Jan-Apr;44(1):24-31. doi: 10.1177/08897077231169566. Epub 2023 May 8. Subst Abus. 2023. PMID: 37226903
• Training Providers of People Who Use Drugs to Offer Hepatitis C Treatment: A Washington State Initiative.

  James JR, Tsui JI. James JR, et al. Subst Abus. 2023 Jan-Apr;44(1):86-90. doi: 10.1177/08897077231167047. Epub 2023 Apr 26. Subst Abus. 2023. PMID: 37226904
• The Association of Vaping With Social/Emotional Health and Attitudes Toward COVID-19 Mitigation Measures in Adolescent and Young Adult Cohorts During the COVID-19 Pandemic.

  Oliver AL, Kossowsky J, Minegishi M, Levy S, Weitzman ER. Oliver AL, et al. Subst Abus. 2023 Jan-Apr;44(1):73-85. doi: 10.1177/08897077231165860. Epub 2023 Apr 26. Subst Abus. 2023. PMID: 37226905 Free PMC article.
• Examining Systems, Substance Use, and Disenfranchisement: Overview and Proceedings of the 2022 AMERSA Conference.

  Bagley SM, Northup R, Wason K, Bratberg J, Gordon AJ, Oliva E. Bagley SM, et al. Subst Abus. 2023 Jan-Apr;44(1):4-11. doi: 10.1177/08897077231169569. Epub 2023 May 8. Subst Abus. 2023. PMID: 37226906 No abstract available.
• More Effective Communication During Inpatient Addiction Treatment.

  Marcovitz DE, Kast KA. Marcovitz DE, et al. Subst Abus. 2023 Jan-Apr;44(1):12-16. doi: 10.1177/08897077231165064. Epub 2023 May 3. Subst Abus. 2023. PMID: 37226907
• Patients' Perceptions of Physical Therapists Addressing Opioid Misuse.

  Magel J, Hartman P, Fritz JM, Koch NN, Dostal H, Vollmer N, Ferguson NL, Tapken J, Cohee K, Cochran G, Gordon AJ. Magel J, et al. Subst Abus. 2023 Jan-Apr;44(1):32-40. doi: 10.1177/08897077231165072. Epub 2023 May 3. Subst Abus. 2023. PMID: 37226908
• A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States.

  Gaeta Gazzola M, Carmichael ID, Christian NJ, Zheng X, Madden LM, Barry DT. Gaeta Gazzola M, et al. Subst Abus. 2023 Jan-Apr;44(1):62-72. doi: 10.1177/08897077231167291. Epub 2023 May 3. Subst Abus. 2023. PMID: 37226909
• "I'm Clean and Sober, But Not Necessarily Free": Perceptions of Buprenorphine Among Patients in Long-Term Treatment.

  Wyse JJ, Lovejoy TI, Gordon AJ, Mackey K, Herreid-O'Neill A, Morasco BJ. Wyse JJ, et al. Subst Abus. 2023 Jan-Apr;44(1):41-50. doi: 10.1177/08897077231165625. Epub 2023 May 3. Subst Abus. 2023. PMID: 37226910 Free PMC article.